MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
17.44
+0.18 (1.04%)
At close: May 5, 2026, 4:00 PM EDT
17.44
0.00 (0.00%)
After-hours: May 5, 2026, 4:01 PM EDT
MediWound Market Cap
MediWound has a market cap or net worth of $224.27 million as of May 5, 2026. Its market cap has increased by 27.39% in one year.
Market Cap
224.27M
Enterprise Value
179.26M
1-Year Change
27.39%
Ranking
Category
Stock Price
$17.44
Market Cap Chart
Since March 20, 2014, MediWound's market cap has decreased from $262.70M to $224.27M, a decrease of -14.63%. That is a compound annual growth rate of -1.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 213.73M | -9.70% |
| Dec 31, 2025 | 236.68M | 23.23% |
| Dec 31, 2024 | 192.06M | 104.85% |
| Dec 29, 2023 | 93.76M | 19.44% |
| Dec 30, 2022 | 78.50M | 22.08% |
| Dec 31, 2021 | 64.30M | -36.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALX Oncology Holdings | 227.41M |
| Keros Therapeutics | 227.36M |
| Nuvectis Pharma | 226.24M |
| Fennec Pharmaceuticals | 225.47M |
| Voyager Therapeutics | 224.09M |
| Camp4 Therapeutics | 210.30M |
| Nkarta | 208.88M |
| Context Therapeutics | 208.57M |